iShares Biotechnology ETF (IBB)
NasdaqGM: IBB
· Real-Time Price · USD
198.26
-0.68 (-0.34%)
At close: Aug 14, 2026, 3:59 PM
198.95
+0.35%
After-hours: 7:54 PM
iShares Biotechnology ETF (IBB) Stock Price, Analysis & Data
-0.34% (1D)
| Bid | 185.09 |
| Market Cap | n/a |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Beta | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | 25.72 |
| Forward PE | n/a |
| P/B (ttm) | 1.23 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 197.12 |
| Volume | 583,570 |
| Avg. Volume (20D) | 1,564,746 |
| Open | 198.00 |
| Previous Close | 198.94 |
| Day's Range | 195.67 - 198.28 |
| 52-Week Range | 136.89 - 201.72 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IBB
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified....
Industry n/a
Sector n/a
IPO Date Feb 12, 2001
Employees n/a
Stock Exchange NasdaqGM
Ticker Symbol IBB
Financial Performance
In undefined, iShares Biotechnology ETF's revenue was n/a, an increase of undefined% compared to the previous year's n/a. Earnings were n/a, an increase of undefined%.
Financial Statements
Page 1 of 2